Journal Article

Molecular subtypes, predictive markers and prognosis in small-cell lung carcinoma

Zhu, Yanli, Zhuo, Minglei, Ren, Wenhao, Li, Sheng, Chi, Kaiwen, Mao, Luning, Wu, Jianghua, Lin, Dongmei, Huang, Xiaozheng, Wang, Haiyue

2025

Overview

AimsA new molecular subtype classification was proposed for small-cell lung carcinoma (SCLC). We aimed to further validate the classification in various SCLC patient samples using immunohistochemistry (IHC) to highlight its clinical significance.MethodsWe analysed the protein expression of four subtype (achaete-scute family BHLH transcription factor 1 (ASCL1), neuronal differentiation 1 (NEUROD1), POU class 2 homeobox 3 (POU2F3) and Yes1-associated transcriptional regulator (YAP1)) and two predictive markers (delta-like ligand 3 (DLL3) and MYC) using IHC in 216 specimens from 195 SCLC patients, including 21 pairs of resected biopsy tumours. Associations among molecular subtypes, clinicopathological features and prognostic implications were also explored.ResultsThe ASCL1, NEUROD1, POU2F3, YAP1, DLL3 and MYC-positive expression rates were 70.3%, 56.9%, 14.9%, 19.0%, 75.4% and 22.6%, respectively. DLL3 expression had positive and negative associations with that of ASCL1 and POU2F3/YAP1, respectively, whereas MYC had the opposite effect. Strong associations of ASCL1 (Ρ=0.8603, p<0.0001), NEUROD1 (Ρ=0.8326, p<0.0001), POU2F3 (Ρ=0.6950, p<0.0001) and YAP1 (Ρ=0.7466, p<0.0001) expressions were detected between paired resected biopsy tumours. In addition to SCLC-A (ASCL1-dominant), SCLC-N (NEUROD1-dominant) and SCLC-P (POU2F3-dominant), unsupervised hierarchical cluster analyses identified a fourth, quadruple-negative SCLC subtype (SCLC-QN) characterised by the low expression of all four subtype-specific proteins, and 55.4% (n=108), 27.2% (n=53), 11.8% (n=23) and 5.6% (n=11) were categorised as SCLC-A, SCLC-N, SCLC-P and SCLC-QN, respectively. Significant enrichment of SCLC-P in the combined SCLC cohort was observed, and adenocarcinoma was more prevalent in SCLC-A, while large-cell neuroendocrine carcinoma was more commonly seen in SCLC-P. No survival difference was found among molecular subtypes.ConclusionsOur results provide clinical insights into the diagnostic, prognostic and predictive significance of SCLC molecular subtype classifications.

• Publisher: BMJ Publishing Group Ltd and Association of Clinical Pathologists,BMJ Publishing Group LTD
• Subject: Adult / Aged / Aged, 80 and over / Basic Helix-Loop-Helix Transcription Factors - analysis / Basic Helix-Loop-Helix Transcription Factors - metabolism / Biomarkers, Tumor / Biomarkers, Tumor - analysis / Biomarkers, Tumor - metabolism / Biopsy / Cancer therapies / Classification / DIAGNOSIS / Female / Hospitals / Humans / IMMUNOHISTOCHEMISTRY / Intracellular Signaling Peptides and Proteins / Kinases / Ligands / Lung cancer / Lung Neoplasms / Lung Neoplasms - diagnosis / Lung Neoplasms - metabolism / Lung Neoplasms - mortality / Lung Neoplasms - pathology / Male / Medical prognosis / Membrane Proteins / Middle Aged / Original research / Patients / Predictive Value of Tests / Prognosis / Radiation therapy / Small Cell Lung Carcinoma - metabolism / Small Cell Lung Carcinoma - pathology / Software / Statistical analysis / Transcription factors / Tumors